![Benjamin Zeskind](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benjamin Zeskind
Fondateur chez
IMMUNEERING CORPORATION
Fortune : 13 M $ au 31/07/2026
Profil
Benjamin J.
Zeskind is the founder of Immuneering Corp., established in 2008, where the titles held include President, Chief Executive Officer & Director since 2008.
The education history includes a doctorate from the Massachusetts Institute of Technology conferred in 2006 and an MBA from Harvard Business School conferred in 2008.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/06/2026 | 3 210 179 ( 4,96% ) | 13 M $ | 31/07/2026 |
Postes actifs de Benjamin Zeskind
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNEERING CORPORATION | Fondateur | 01/01/2008 |
Formation de Benjamin Zeskind
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
